Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 11/20 | 0.62 |
| ▸ | MAP1LC3B | Q9GZQ8 | 3/20 | 0.58 |
| ▸ | IKZF3 | Q9UKT9 | 3/20 | 0.58 |
| ▸ | IKZF1 | Q13422 | 2/20 | 0.58 |
| ▸ | BRD4 | O60885 | 2/20 | 0.58 |
| ▸ | DDB1 | Q16531 | 2/20 | 0.58 |
| ▸ | TNF | P01375 | 1/20 | 0.58 |
| ▸ | IL1B | P01584 | 1/20 | 0.58 |
| ▸ | STAT3 | P40763 | 1/20 | 0.54 |
| ▸ | AXL | P30530 | 5/20 | 0.53 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.52 |
| ▸ | JAK2 | O60674 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28909798 | 1.00 | CRBN (0.62) | CRBNMAP1LC3BIKZF3IKZF1BRD4 | |
| SCHEMBL17536564 | 0.96 | CRBN (0.64) | CRBNMAP1LC3BIKZF3IKZF1BRD4 | |
| SCHEMBL17536572 | 0.92 | CRBN (0.67) | CRBNMAP1LC3BIKZF3IKZF1BRD4 | |
| SCHEMBL19747349 | 0.90 | CRBN (0.61) | CRBNMAP1LC3BIKZF3IKZF1BRD4 | |
| SCHEMBL22959613 | 0.90 | CRBN (0.59) | CRBNMAP1LC3BIKZF3IKZF1BRD4 | |
| SCHEMBL24142000 | 0.90 | CRBN (0.61) | CRBNMAP1LC3BIKZF3IKZF1BRD4 | |
| SCHEMBL22940891 | 0.90 | CRBN (0.59) | CRBNMAP1LC3BIKZF3IKZF1BRD4 | |
| SCHEMBL21814682 | 0.90 | CRBN (0.61) | CRBNMAP1LC3BIKZF3IKZF1BRD4 | |
| SCHEMBL22636509 | 0.90 | CRBN (0.61) | CRBNMAP1LC3BIKZF3IKZF1BRD4 | |
| SCHEMBL27925246 | 0.90 | CRBN (0.59) | CRBNMAP1LC3BIKZF3IKZF1BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4107152-A1 | BCL-2 PROTEIN INHIBITORS | Recurium IP Holdings, LLC (US) | 2022-12-28 | — | — | EP | disclosed |
| CN-115461335-A | BCL-2 protein inhibitors | 里科瑞尔姆IP控股有限责任公司 | 2022-12-09 | — | — | CN | disclosed |